72162-1610 : Rivastigmine Transdermal System Transdermal System 13.3 mg/24h Transdermal Patch, Extended Release


NDC: 72162-1610
Labeler: Bryant Ranch Prepack
Product Type: Human Prescription Drug
Drug Name:  Rivastigmine Transdermal System
Dosage Form: Transdermal Patch, Extended Release
Application #: ANDA209063
Rev. Date: 


NDC Package Codes:

  • 72162-1610-3: 30 POUCH IN 1 CARTON (72162‑1610‑3) / 1 PATCH IN 1 POUCH / 24 H IN 1 PATCH

Active Ingredients:

  • Rivastigmine

Dosage Strength:

  • 13.3 mg/24h

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 72162-1608 Rivastigmine Transdermal System Transdermal System 4.6 mg/24h Transdermal Patch, Extended Release by Bryant Ranch Prepack
  • 72162-1609 Rivastigmine Transdermal System Transdermal System 9.5 mg/24h Transdermal Patch, Extended Release by Bryant Ranch Prepack
  • 63629-2064 Rivastigmine Transdermal System Transdermal System 13.3 mg/24h Transdermal Patch, Extended Release by Bryant Ranch Prepack
  • 63629-2065 Rivastigmine Transdermal System Transdermal System 4.6 mg/24h Transdermal Patch, Extended Release by Bryant Ranch Prepack
  • 63629-2066 Rivastigmine Transdermal System Transdermal System 9.5 mg/24h Transdermal Patch, Extended Release by Bryant Ranch Prepack
  • 63629-8807 Rivastigmine Transdermal System Transdermal System 9.5 mg/24h Transdermal Patch, Extended Release by Bryant Ranch Prepack
  • 63629-8846 Rivastigmine Transdermal System Transdermal System 13.3 mg/24h Transdermal Patch, Extended Release by Bryant Ranch Prepack
  • 47781-304 Rivastigmine Transdermal System 4.6 mg Transdermal Patch, Extended Release by Alvogen Inc.
  • 47781-305 Rivastigmine Transdermal System 9.5 mg Transdermal Patch, Extended Release by Alvogen Inc.
  • 47781-405 Rivastigmine Transdermal System 13.3 mg Transdermal Patch, Extended Release by Alvogen Inc.
  • 51991-897 Rivastigmine Transdermal System Transdermal System 4.6 mg/24h Transdermal Patch, Extended Release by Breckenridge Pharmaceutical, Inc.
  • 51991-898 Rivastigmine Transdermal System Transdermal System 9.5 mg/24h Transdermal Patch, Extended Release by Breckenridge Pharmaceutical, Inc.
  • 51991-899 Rivastigmine Transdermal System Transdermal System 13.3 mg/24h Transdermal Patch, Extended Release by Breckenridge Pharmaceutical, Inc.
  • 72855-100 Rivastigmine Transdermal System Transdermal System 4.6 mg/24h Transdermal Patch, Extended Release by Adhexpharma
  • 72855-101 Rivastigmine Transdermal System Transdermal System 9.5 mg/24h Transdermal Patch, Extended Release by Adhexpharma
  • 72855-102 Rivastigmine Transdermal System Transdermal System 13.3 mg/24h Transdermal Patch, Extended Release by Adhexpharma

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 72162-1610 QR Code

< Prev: 72162-1609Next: 72162-1612 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.